JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brynne, L.
Right arrow Articles by Karlsson, M. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brynne, L.
Right arrow Articles by Karlsson, M. O.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PROPRANOLOL HYDROCHLORIDE

Vol. 294, Issue 3, 1201-1208, September 2000

Consequence of Exercise on the Cardiovascular Effects of l-Propranolol in Spontaneously Hypertensive Rats1

Lena Brynne2, Lennart K. Paalzow and Mats O. Karlsson

Department of Pharmacy, Division of Biopharmaceutics and Pharmacokinetics, Uppsala University, Uppsala, Sweden

The aim of this study was to elucidate time dependence in the development of rebound effect and to quantify the cardiovascular effects of chronic l-propranolol infusions in spontaneously hypertensive rats. Heart rate and systolic and diastolic blood pressures were monitored both during exercise performance and later by using telemetry. The pharmacodynamics were determined after different infusion lengths of l-propranolol (4 mg/kg/day) or placebo for 4, 8, or 12 days. A pronounced reduction in heart rate over time was found, which was interpreted as a positive influence of exercise on heart rate and was less marked in drug-treated animals. A mechanism-based model that accounts for competitive antagonism, spare receptors, the positive influence of exercise on heart rate, and circadian variations was used to describe the data. An empirical effect compartment model with an Emax model was related to a circadian baseline and describes the relationship between plasma concentrations and reduction in blood pressures. The potencies for exercise and postexercise systolic blood pressure were similar with EC50 values of 48 and 56 ng/ml, and the corresponding maximal effects were 17.8 and 21.9%, respectively. The EC50 values and maximal effects for diastolic blood pressure were 26 and 5 ng/ml and 20.6 and 21.0%, respectively. The effect of l-propranolol could be quantified by a mechanism-based model in the presence of a positive influence of exercise on the heart rate. The effect of l-propranolol on the blood pressures is best described by an effect compartment model with circadian variations.


1 This study was financed in part by the Swedish Pharmaceutical Society, Sweden.

2 Present address: Pharmacia & Upjohn AB, Drug Metabolism Research, Lindhagensgatan 133, SE-112 87 Stockholm, Sweden.


0022-3565/00/2943-1201$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Ann Rheum DisHome page
M L E Andersson, I F Petersson, K E Karlsson, E N Jonsson, B Mansson, D Heinegard, and T Saxne
Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis
Ann Rheum Dis, November 1, 2006; 65(11): 1490 - 1494.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.